Thyroiditis (subacute De Quervain, postpartum, on immunotherapy)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Painful thyroid (subacute thyroiditis)
Laboratory tests
- TSH
- Free T4
- CRP
- TSH receptor antibodies (if doubt with Graves' disease)if neededAtypical presentation (mild pain, normal CRP): TRAb are positive in Graves' disease, absent or low in subacute thyroiditis [2,3].
Later, after the painful phase
- TSH
Also consider
- On amiodarone? Drug-induced thyroiditis comes under the page "Treatment: amiodarone".
- On lithium? Drug-induced thyroiditis comes under the page "Treatment: lithium".
- Persistently raised TSH? For persistently raised TSH (Hashimoto), see the page "Hypothyroidism".
Do not order
After childbirth (postpartum thyroiditis)
Laboratory tests
- TSH
- Free T4
- TSH receptor antibodies (if TSH low: exclude Graves' disease)if neededPostpartum thyrotoxicosis: TRAb distinguish Graves' disease from thyroiditis, especially during breastfeeding, when scintigraphy is not possible [1].
- Anti-TPO antibodies (if TSH raised, in the absence of a previous positive result)if neededHypothyroid phase: positive anti-TPO antibodies indicate an autoimmune cause [1]; a previous positive result is not rechecked [8].
Also consider
- On amiodarone? Drug-induced thyroiditis comes under the page "Treatment: amiodarone".
- On lithium? Drug-induced thyroiditis comes under the page "Treatment: lithium".
- Persistently raised TSH? For persistently raised TSH (Hashimoto), see the page "Hypothyroidism".
On cancer immunotherapy
Before the first injection, then before each course (first 3 to 6 months)
- TSH
- Free T4 (anti-CTLA-4, or unexplained low TSH)if neededRisk of hypophysitis with central hypothyroidism, especially on anti-CTLA-4: low TSH with low free T4 [10].
- 8 am serum cortisol (if low TSH with low free T4, before any levothyroxine)if needednon-French guidelineLow TSH with low free T4 on immunotherapy: think of hypophysitis. The ESE (2022) and the UK Society for Endocrinology (2018) ask for cortisol deficiency to be excluded before any levothyroxine, which can trigger an adrenal crisis [11,12]. The 2018 French opinion on the thyroid does not address this point [10]; see the page "Treatment: cancer immunotherapy".
- Anti-TPO antibodies (if TSH between 5 and 10 mIU/L)if neededHypothyroidism with TSH < 10 mIU/L: anti-TPO antibodies help to decide on levothyroxine [10].
- TSH receptor antibodies (severe thyrotoxicosis or diagnostic doubt)if neededWhen in doubt between drug-induced thyroiditis and another cause of hyperthyroidism, in particular if the thyrotoxicosis is severe [10].
- Then: TSH every 2 months for 6 months, then if symptoms.
Do not order
- Anti-TPO or TSH receptor antibodies as routine screening before immunotherapy: not recommended, TSH is enough [10].
Sources (13)
- Inaba H, Akamizu T. Postpartum thyroiditis. In: Feingold KR, Adler RA, Ahmed SF, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com; mise à jour du 8 mai 2018 (synthèse d'expert, pas une recommandation).
- Haute Autorité de santé. Prise en charge des hyperthyroïdies en population générale. Recommandation de bonne pratique (fiche mémo), validée par le Collège le 15 décembre 2022.
- Hennessey JV. Subacute thyroiditis. In: Feingold KR, Adler RA, Ahmed SF, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com; mise à jour du 7 janvier 2026 (synthèse d'expert, pas une recommandation).
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1208 et 1211 (TSH, TSH + T4L), 1487 (anticorps anti-TPO) et 1488 (anticorps anti-récepteurs de la TSH).
- National Institute for Health and Care Excellence. Thyroid disease: assessment and management. NICE guideline NG145, 2019, mise à jour en 2023.
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.
- Sweeney LB, Stewart C, Gaitonde DY. Thyroiditis: an integrated approach. Am Fam Physician. 2014;90(6):389-396.
- Haute Autorité de santé. Prise en charge des hypothyroïdies chez l'adulte. Recommandation de bonne pratique, validée par le Collège en décembre 2022.
- Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389.
- Illouz F, Drui D, Caron P, Do Cao C. Expert opinion on thyroid complications in immunotherapy (avis d'experts de la Société française d'endocrinologie). Ann Endocrinol (Paris). 2018;79(5):555-561.
- Husebye ES, Castinetti F, Criseno S, et al. Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline. Eur J Endocrinol. 2022;187(6):G1-G21.
- Higham CE, Olsson-Brown A, Carroll P, et al. Society for Endocrinology Endocrine Emergency Guidance: Acute management of the endocrine complications of checkpoint inhibitor therapy. Endocr Connect. 2018;7(7):G1-G7.
- Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(17):1714-1768.